PepsiCo's CEO expands his tech governance role at IBM, while a new financial chief takes the helm in the critical India region. These moves come as the beverage and snack giant's stock shows resilience, prompting investor analysis of its future direction.
Amidst sluggish sales and intense competition, Target appoints Michael Fiddelke as CEO and refreshes its board, placing store revitalization and operational efficiency at the heart of its turnaround strategy.
Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.
The Walt Disney Company exceeded Wall Street expectations in its fiscal first quarter, delivering robust results across its entertainment, experiences, and streaming divisions as longtime CEO Bob Iger prepares to hand over the reins later this year.
Facing internal resistance to AI adoption, payments company MassPay linked its use directly to a profit-sharing pool. The result, according to CEO Ran Grushkowsky, was not just significant cost savings and eliminated hiring needs, but a notable boost in team morale.
A new survey by the American Chamber of Commerce in Hong Kong reveals a significant uptick in business optimism for 2026, with over half of senior executives expressing a positive outlook despite persistent U.S.-China tensions and global uncertainty.
ABIVAX (NASDAQ:ABVX) shares have skyrocketed over 2000% in recent months, fueled by speculation of an Eli Lilly buyout and promising clinical data for its lead drug. CEO Marc De Garidel has publicly dismissed the acquisition rumors as 'noise,' redirecting focus to the company's financing needs and advancing therapeutic programs.
While CeoTronics AG's (FRA:CEK) recent earnings report failed to ignite its stock price, a deeper look reveals a robust cash conversion story that may please long-term shareholders and point to healthier fundamentals than the headline profit figure suggests.
Nvidia is set to make a landmark investment in OpenAI's latest funding round, CEO Jensen Huang confirmed, signaling a deepening alliance between the AI hardware giant and the leading AI research lab. However, reports of internal skepticism at Nvidia introduce uncertainty into the final terms and timing of the deal.
Disney's iconic leader, who returned to steady the company in 2022, is reportedly preparing to exit the CEO role ahead of his contract's expiration, setting the stage for a high-stakes succession search.
GameStop's stock jumped nearly 5% Friday after the company announced plans for a billion-dollar acquisition, described by CEO Ryan Cohen as a potentially 'transformational' move for the retailer and the markets.
Disney's board is set to convene next week to vote on a successor for CEO Bob Iger, who is now expected to depart before his contract ends in 2026, aiming to give his replacement a 'fresh start'.
Altria Group names CFO Salvatore Mancuso as its incoming CEO, accelerating its smoke-free transition while taking a massive impairment charge on past investments, signaling a sharp strategic reassessment.
SoFi CEO Anthony Noto calls the Powell Fed era a mixed bag, praising the ultimate economic stability despite policy stumbles. As the baton passes to a new Treasury Secretary, investors weigh SoFi's record growth against a cautious 2026 outlook.
Five years after its meme-stock frenzy, GameStop is aiming for a colossal acquisition to transform its business. CEO Ryan Cohen could earn a $35 billion payday if he succeeds in reaching a $100 billion market cap—a goal experts call wildly ambitious.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
Peter McGuinness, the CEO who sought to reposition plant-based meat for mainstream consumers by moving beyond climate messaging, is departing Impossible Foods. His exit comes as the broader alternative protein sector faces significant sales declines and strategic recalibration.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
CEO Brian Niccol says employees' questions about share prices reflect pride and care, as the coffee giant navigates workplace reforms and ongoing labor disputes.
A UK tribunal has allowed a massive lawsuit accusing Valve of anti-competitive practices to proceed, drawing vocal support from Epic Games CEO Tim Sweeney, who calls Steam the last major platform clinging to restrictive payment rules.
